Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03253666 |
Recruitment Status :
Completed
First Posted : August 18, 2017
Last Update Posted : July 15, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Skin Cancer Melanoma Non-melanoma Skin Cancer Psoriasis Rosacea Lupus Erythematosus Atopic Dermatitis | Other: Nutrient Intake |
The study population consisted of two ongoing cohorts: the Nurses' Health Study (NHS) and Health Professionals Follow-Up Study (HPFS). The NHS began in 1976 when 121,700 female nurses aged 33-55 years and residing in the United States responded to a baseline questionnaire. The HPFS began in 1986 when 51,529 male health professionals aged 40-75 years and residing in the United States completed a similar baseline questionnaire. Study investigators sent follow-up questionnaires biennially to participants to update information on past medical history as well as lifestyle factors.
Follow up was started in 1984 for the NHS and 1986 for the HPFS when diet was measured with an expanded food frequency questionnaire (FFQ). Participants in the NHS responded to an ~130 item semi-quantitative FFQ in 1984, 1986, and then every four years thereafter, while those in the HPFS responded to a similar FFQ in 1986 and then every four years thereafter. The FFQ collected information on average intake of each food item over the past year. It also specified a common serving size for each item. Participants could select from one of nine intake frequency choices, ranging from less than once per month to six or more times per day. Participants also provided information on current use and dose of multivitamins and use of other vitamin supplements.
For both cohorts, investigators repeatedly collected and updated information on several anthropometric and lifestyle factors such as weight, smoking status, alcohol use, coffee intake, and physical activity level. Information was also collected on several major risk factors for skin disease such as family history of melanoma, number of arm moles, natural hair color, sunburn susceptibility as a child or adolescent, number of lifetime blistering sunburns, type of tan after repeated sun exposure as a child or adolescent, and cumulative ultraviolet flux since baseline.
Study subjects reported new diagnoses biennially. After obtaining permission from participants, their medical and pathological records were acquired. Study physicians blinded to questionnaire information reviewed these records to confirm diagnoses
The study was approved by the institutional review boards of both Brigham and Women's Hospital and Harvard T.H Chan School of Public Health.
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 173229 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 30 Years |
Official Title: | Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) |
Actual Study Start Date : | January 2017 |
Actual Primary Completion Date : | May 2018 |
Actual Study Completion Date : | May 2018 |
Group/Cohort | Intervention/treatment |
---|---|
Nurses' Health Study
See "Detailed Description"
|
Other: Nutrient Intake
Dietary nutrient intake (such as folate) and supplemental nutrient intake (such as folic acid) |
Health Professionals Follow-Up Study
See "Detailed Description"
|
Other: Nutrient Intake
Dietary nutrient intake (such as folate) and supplemental nutrient intake (such as folic acid) |
- Multiple skin diseases [ Time Frame: Skin disease/cancer [ NHS: Time Frame: 1984 - 2010 ] [ HPFS: Time Frame: 1986 - 2010 ]. Person time contribution from date of return of questionnaire to date of first report of skin disease/death/end of follow-up (whichever came first) ]Includes skin cancer, psoriasis, and other inflammatory and autoimmune skin diseases.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
-Participants of these two cohorts
Exclusion Criteria:
- Participants with missing data on dietary intake at baseline
- Participants with a prior history of cancer (except non-melanoma skin cancer)
- For skin cancer, non-white participants because of low risk of skin cancer (such as melanoma) and small numbers.
- For melanoma, participants with in-situ melanomas, which comprise tumours restricted to the epidermis of the skin.
Publications of Results:
Responsible Party: | Ashar Dhana, Research Associate, Harvard School of Public Health (HSPH) |
ClinicalTrials.gov Identifier: | NCT03253666 |
Other Study ID Numbers: |
CA186107 |
First Posted: | August 18, 2017 Key Record Dates |
Last Update Posted: | July 15, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Skin Neoplasms Psoriasis Dermatitis Rosacea |
Neoplasms Neoplasms by Site Skin Diseases Skin Diseases, Papulosquamous |